← All candidates
45 insider filings on record.
45 filings on record.
ETONEton Pharmaceuticals, Inc.
NasdaqGM · Healthcare · $1.61B
$56.35
+2.59% · Sep 16
45 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 18 sells◆ 9 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.61B
Float
22.3M
78% public
Short % float
Pro
Price / profit
140.9
Price / future profit
21.8
Price / sales
15.3
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Opaleye Management Inc.
Bought $79.1K on Jun 10 — 5,000 sh @ $15.82, held indirect, 0.2% of their stake.
2 of 5 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
40 more transactions on Pro →Context
Wall St
$45.67 avg target
-19.0% vs today · 3 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26$0.14 act+$0.00
Q4 '25$0.19 act−$0.01
Q3 '25$0.04 act−$0.12
Q2 '25$0.03 act+$0.01
Coverage
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth StrategyInsider Monkey · 05-23Eton Pharmaceuticals, Inc. Just Missed EPS By 44%: Here's What Analysts Think Will Happen NextSimply Wall St. · 05-16Eton (ETON) Q1 2026 Earnings Call TranscriptMotley Fool · 05-15Eton Pharmaceuticals, Inc. Q1 2026 Earnings Call SummaryMoby · 05-15
The file stays open
45 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice